230 related articles for article (PubMed ID: 30192018)
1. Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study.
Gilbert DL; Murphy TK; Jankovic J; Budman CL; Black KJ; Kurlan RM; Coffman KA; McCracken JT; Juncos J; Grant JE; Chipkin RE
Mov Disord; 2018 Aug; 33(8):1272-1280. PubMed ID: 30192018
[TBL] [Abstract][Full Text] [Related]
2. Ecopipam for Tourette Syndrome: A Randomized Trial.
Gilbert DL; Dubow JS; Cunniff TM; Wanaski SP; Atkinson SD; Mahableshwarkar AR
Pediatrics; 2023 Feb; 151(2):. PubMed ID: 36628546
[TBL] [Abstract][Full Text] [Related]
3. A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome.
Gilbert DL; Budman CL; Singer HS; Kurlan R; Chipkin RE
Clin Neuropharmacol; 2014; 37(1):26-30. PubMed ID: 24434529
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Glutamate Modulators in Tic Suppression: A Double-Blind, Randomized Control Trial of D-serine and Riluzole in Tourette Syndrome.
Lemmon ME; Grados M; Kline T; Thompson CB; Ali SF; Singer HS
Pediatr Neurol; 2015 Jun; 52(6):629-34. PubMed ID: 26002052
[TBL] [Abstract][Full Text] [Related]
5. A placebo-controlled trial of risperidone in Tourette syndrome.
Scahill L; Leckman JF; Schultz RT; Katsovich L; Peterson BS
Neurology; 2003 Apr; 60(7):1130-5. PubMed ID: 12682319
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial.
Coffey B; Jankovic J; Claassen DO; Jimenez-Shahed J; Gertz BJ; Garofalo EA; Stamler DA; Wieman M; Savola JM; Gordon MF; Alexander JK; Barkay H; Harary E
JAMA Netw Open; 2021 Oct; 4(10):e2129397. PubMed ID: 34661664
[TBL] [Abstract][Full Text] [Related]
7. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial.
Jankovic J; Coffey B; Claassen DO; Jimenez-Shahed J; Gertz BJ; Garofalo EA; Stamler DA; Wieman M; Savola JM; Gordon MF; Alexander J; Barkay H; Harary E
JAMA Netw Open; 2021 Oct; 4(10):e2128204. PubMed ID: 34609495
[TBL] [Abstract][Full Text] [Related]
9. Tic reduction with pergolide in a randomized controlled trial in children.
Gilbert DL; Dure L; Sethuraman G; Raab D; Lane J; Sallee FR
Neurology; 2003 Feb; 60(4):606-11. PubMed ID: 12601100
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder.
Nicolson R; Craven-Thuss B; Smith J; McKinlay BD; Castellanos FX
J Am Acad Child Adolesc Psychiatry; 2005 Jul; 44(7):640-6. PubMed ID: 15968232
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trials of the D1/D5 antagonist ecopipam for weight loss in obese subjects.
Astrup A; Greenway FL; Ling W; Pedicone L; Lachowicz J; Strader CD; Kwan R;
Obesity (Silver Spring); 2007 Jul; 15(7):1717-31. PubMed ID: 17636090
[TBL] [Abstract][Full Text] [Related]
12. A double blind randomized placebo control trial of levetiracetam in Tourette syndrome.
Smith-Hicks CL; Bridges DD; Paynter NP; Singer HS
Mov Disord; 2007 Sep; 22(12):1764-70. PubMed ID: 17566124
[TBL] [Abstract][Full Text] [Related]
13. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Otasowie J; Castells X; Ehimare UP; Smith CH
Cochrane Database Syst Rev; 2014 Sep; (9):CD006997. PubMed ID: 25238582
[TBL] [Abstract][Full Text] [Related]
14. Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial.
Gilbert DL; Sethuraman G; Sine L; Peters S; Sallee FR
Neurology; 2000 Mar; 54(6):1310-5. PubMed ID: 10746603
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome.
Hedderick EF; Morris CM; Singer HS
Pediatr Neurol; 2009 Jun; 40(6):420-5. PubMed ID: 19433274
[TBL] [Abstract][Full Text] [Related]
16. A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.
Spencer T; Biederman J; Coffey B; Geller D; Crawford M; Bearman SK; Tarazi R; Faraone SV
Arch Gen Psychiatry; 2002 Jul; 59(7):649-56. PubMed ID: 12090818
[TBL] [Abstract][Full Text] [Related]
17. Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans.
Haney M; Ward AS; Foltin RW; Fischman MW
Psychopharmacology (Berl); 2001 Jun; 155(4):330-7. PubMed ID: 11441422
[TBL] [Abstract][Full Text] [Related]
18. Short-term sulpiride treatment of children and adolescents with Tourette syndrome or chronic tic disorder.
Ho CS; Chen HJ; Chiu NC; Shen EY; Lue HC
J Formos Med Assoc; 2009 Oct; 108(10):788-93. PubMed ID: 19864199
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome.
McCracken JT; Suddath R; Chang S; Thakur S; Piacentini J
J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):501-8. PubMed ID: 18928414
[TBL] [Abstract][Full Text] [Related]
20. A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome.
Kurlan R; Crespi G; Coffey B; Mueller-Vahl K; Koval S; Wunderlich G;
Mov Disord; 2012 May; 27(6):775-8. PubMed ID: 22407510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
